SCHEMBL23871973

SCHEMBL23871973

CCCC(=O)NC1=CCCC=C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.43
ALDH1A1 P00352 3/20 0.42
MAPT P10636 2/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.40
NSD2 O96028 1/20 0.38
TTR P02766 1/20 0.38
ADORA1 P30542 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
THRB P10828 2/20 0.37
ADORA3 P0DMS8 1/20 0.37
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
THRA P10827 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27358463 0.87 CETP (0.43) NPC1RAB9ASMN1; SMN2CA1CA2
SCHEMBL20867336 0.81 HDAC1 (0.36) LMNAHDAC3HDAC1HDAC2HDAC8
SCHEMBL22019074 0.80 NPC1 (0.38) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL10180988 0.79 CNR1 (0.55) TP53ALDH1A1MAPTHPGDMAPK1
SCHEMBL5960697 0.76 SMN1; SMN2 (0.34) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL20861736 0.75 HDAC1 (0.35) ALDH1A1MEN1KMT2AHDAC3HDAC1
SCHEMBL24202123 0.75 TP53 (0.42) TP53ALDH1A1MAPTHPGDMAPK1
SCHEMBL21133081 0.73 TP53 (0.41) TP53ALDH1A1MAPTHPGDMAPK1
SCHEMBL18425800 0.73 TP53 (0.41) TP53ALDH1A1MAPTHPGDMAPK1
SCHEMBL10140100 0.73 ALDH1A1 (0.39) ALDH1A1MAPTSMN1; SMN2KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021191219-A1 N-PHENYL-3-MERCAPTOPROPANAMIDE DERIVATIVES AS METALLO-BETA-LACTAMASE INHIBITORS FOR THE TREATMENT OF BACTERIAL INFECTIONS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-09-30 WO disclosed